Reunion Gold Announces Approval to Extend Warrants
LONGUEUIL, Quebec, Aug. 26, 2020 (GLOBE NEWSWIRE) — Reunion Gold Corporation (TSX-V: RGD) (the “Company”) announces that it has received […]
KYE Pharmaceuticals and Catalyst Pharmaceuticals Challenge Health Canada’s Decision to Overlook Firdapse® Data Exclusivity
CORAL GABLES, Fla., Aug. 26, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]
Verizon Response: unlimited call/text/data for customers in Hurricane Laura’s Path
For media: we have b-roll, pictures and additional information on our emergency response equipment available at our Emergency Resource Center […]
Ethertronics Completes Development and Full Mass Production Release of First UWB Antenna Solutions for Samsung Electronics
FOUNTAIN INN, S.C., Aug. 26, 2020 (GLOBE NEWSWIRE) — AVX Corporation, a leading manufacturer and supplier of advanced electronic components […]
Atossa Therapeutics to Present at the LD Micro 500 Virtual Conference on September 4, 2020
SEATTLE, Aug. 26, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and […]
How Cars Are Helping Americans Cope During COVID-19
SANTA MONICA, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) — TrueCar, Inc., the most efficient and transparent online destination to find […]
Nova LifeStyle’s Diamond Sofa to Complement Live Appointments with Virtual Tours at Las Vegas Market Summer 2020
LOS ANGELES, Aug. 26, 2020 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced, […]
BIO-key Responds to Inaccurate News Release
WALL, N.J., Aug. 26, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access […]
TSX News -
Dividend 15 Split Corp. Completes Overnight Offering of $20,000,000
TORONTO, Aug. 26, 2020 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. (the “Company”) is pleased to announce it has completed […]
Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19
TORONTO, Aug. 26, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty […]
